Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons

Cancer

Volumn 107, Issue 3, 2006, Pages 554-562

  McHugh, Jonathan B ^a   Thomas, Dafydd G ^a   Herman, Joseph M ^b   Ray, Michael E ^b   Baker, Laurence H ^a   Adsay, N Volkan ^c   Rabah, Raja ^c   Lucas, David R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone neoplasms; Ezrin; Jaw neoplasms; Ki 67 antigen; MIB 1 antibody; Osteosarcoma; p53 gene; Protein p53; Radiotherapy

Indexed keywords

EZRIN; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE TUMOR; CANCER GRADING; CANCER PATIENT; CHILD; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAW TUMOR; MALE; MANDIBLE TUMOR; MAXILLA TUMOR; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; OSTEOSARCOMA; PROGNOSIS; SKULL NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33746305871     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22019     Document Type: Article

References (34)

1. Caron AS, Hajdu SI, Strong EW. Osteogenic sarcoma of the facial and cranial bones. A review of forty-three cases. Am J Surg. 1971;122:719-725.
2. Junior AT, de Abreu Alves F, Pinto CA, Carvalho AL, Kowalski LP, Lopes MA. Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas. Oral Oncol. 2003;39:521-530.
3. Patel SG, Meyers P, Huvos AG, et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer. 2002;95:1495-1503.
4. Mardinger O, Givol N, Talmi YP, Taicher S. Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:445-451.
5. Garrington GE, Scofield HH, Cornyn J, Hooker SP. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer. 1967;20:377-391.
6. Unni KK, Dahlin DC. Dahlin's bone tumors: general aspects and data on 11,087 cases, 5th ed. Philadelphia: Lippincott-Raven, 1996.
7. Delgado R, Maafs E, Alfeiran A, et al. Osteosarcoma of the jaw. Head Neck. 1994;16:246-252.
8. Bennett JH, Thomas G, Evans AW, Speight PM. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:323-332.
9. Arlen M, Shan IC, Higinbotham N, Huvos AJ. Osteogenic sarcoma of head and neck induced, by radiation therapy. N Y State J Med. 1972;72:929-934.
10. Weatherby RP, Dahlin DC, Ivins JC. Postradiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc. 1981;56:294-306.
11. Mark RJ, Poen J, Tran LM, Fu YS, Selch MT, Parker RG. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer. 1994;73:2653-2662.
12. Arlen M, Higinbotham NL, Huvos AG, Marcove RC, Miller T, Shah IC. Radiation-induced sarcoma of bone. Cancer. 1971;28:1087-1099.
13. Sagerman RH, Cassady JR, Tretter P, Ellsworth RM. Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med. 1969;105:529-535.
14. Shah IC, Arlen M, Miller T. Osteogenic sarcoma developing after radiotherapy for retinoblastoma. Am Surg. 1974;40:485-490.
15. Unni KK, Dahlin DC. Osteosarcoma: pathology and classification. Semin Roentgenol. 1989;24:143-152.
16. Ha PK, Eisele DW, Frassica FJ, Zahurak ML, McCarthy EF. Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope. 1999;109:964-969.
17. Oda D, Bavisotto LM, Schmidt RA, et al. Head and neck Osteosarcoma at the University of Washington. Head Neck. 1997;19:513-523.
18. Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival of craniofacial Osteosarcoma: a systematic review of 201 patients. J Clin Oncol. 1997;15:363-367.
19. Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer. 2001;94:1-5.
20. de Vos S, Wilczynski SP, Fleischhacker M, Koeffler P. p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol Oncol. 1994;54:205-208.
21. Gokgoz N, Wunder JS, Mousses S, Eskandarian S, Bell RS, Andrulis IL. Comparison of p53 mutations in patients with localized Osteosarcoma and metastatic Osteosarcoma. Cancer. 2001;92:2181-2189.
22. Radig K, Schneider-Stock R, Haeckel C, Neumann W, Roessner A. p53 gene mutations in osteosarcomas of low-grade malignancy. Hum Pathol. 1998;29:1310-1316.
23. Slootweg PJ, Muller H. Osteosarcoma of the jaw bones. Analysis of 18 cases. J Maxillofac Surg. 1985;13:158-166.
24. Huvos AG, Woodard HQ, Cahan WG, et al. Postradiation Osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer. 1985;55:1244-1255.
25. Hauben EI, Weeden S, Pringle J, Van Marck EA, Hogendoorn PC. Does the histological subtype of high-grade central Osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer. 2002;38:1218-1225.
26. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342:705-708.
27. Nakanishi H, Tomita Y, Myoui A, et al. Mutation of the p53 gene in postradiation sarcoma. Lab Invest. 1998;78:727-733.
28. Oliveira P, Nogueira M, Pinto A, Almeida MO. Analysis of p53 expression in osteosarcoma of the jaw: correlation with clinicopathologic and DNA ploidy findings. Hum Pathol. 1997;28:1361-1365.
29. Lopes MA, Nikitakis NG, Ord RA, Sauk J Jr. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Oral Oncol. 2001;37:566-571.
30. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10:182-186.
31. Leonard P, Sharp T, Henderson S, et al. Gene expression array profile of human osteosarcoma. Br J Cancer. 2003;89:2284-2288.
32. Park HR, Park YK. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone. J Korean Med Sci. 1995;10:360-367.
33. Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology. 1984;91:1351-1355.
34. Chauveinc L, Mosseri V, Quintana E, et al. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet. 2001;22:77-88.